Black Diamond Therapeutics, Inc. (BDTX) stock
BDTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.52−0.09 (-5.59%)
Close on Nov 12, 2026Market cap $87.33MP/E –Yield –
Black Diamond Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Black Diamond Therapeutics's enterprise value was -$18.02M on Nov 11, 2026, against $82.02M a year earlier. Over the last 5 years it ranged from -$122.96M to $221.12M, with a median of -$1.64M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$18.02M | -727.9% |
| 2025 | Dec 31, 2025 | $2.87M | -65.3% |
| 2024 | Dec 31, 2024 | $8.27M | +886.4% |
| 2023 | Dec 29, 2023 | $838.87K | – |
| 2022 | Dec 30, 2022 | -$78.72M | – |
| 2021 | Dec 31, 2021 | -$41.91M | -105.1% |
| 2020 | Dec 31, 2020 | $819.56M | – |
See a number that looks wrong?